BioNTech Buys German Factory to Boost Covid Vaccine Capacity

Bookmark
(Bloomberg) -- BioNTech SE is buying a German manufacturing site with capacity to churn out 750 million doses a year of its Covid-19 vaccine, more than doubling the amount the company can produce a...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.